With headquarters in Bagsvaerd, Copenhagen, Denmark, and production facilities in seven countries, Novo Nordisk employs nearly 30,000 individuals in more than 75 countries. The company has been voted among the best places to work in Europe, Africa, and the Americas, and it offers associates rewarding work, professional growth opportunities, and flexible work options. In the past, Novo Nordisk has hired for freelance and remote jobs in a variety of fields in assorted global locations. Ideal applicants share the company's commitment to its Triple Bottom Line Principle, a strategic initiative focused on financial, social, and environmental responsibility and sustainability.

As an employer, Novo Nordisk offers an opportunity for its team to positively impact the well-being of the greater global community by improving treatments and results for people with diabetes and chronic diseases. It has also been recognized as one of "Canada's Top 100 Employers," one of Forbes magazine's "Most Sustainable Companies," and among "America's 100 Best Adoption-Friendly Workplaces."

Since 1923, Novo Nordisk, an international healthcare company, has been a world leader in diabetes care. With a people-centered approach, the company aims to be an impetus for comprehensive change in diabetes care, education, and public policy. Novo Nordisk also plays a leading role in growth hormone therapy, hormone replacement therapy, and hemophilia care, providing high-quality products to hundreds of countries around the world.

With headquarters in Bagsvaerd, Copenhagen, Denmark, and production facilities in seven countries, Novo Nordisk employs nearly 30,000 individuals in more than 75 countries. The company has been voted among the best places to work in Europe, Africa, and the Americas, and it offers associates rewarding work, professional growth opportunities, and flexible work options. In the past, Novo Nordisk has hired for freelance and remote jobs in a variety of fields in assorted global locations. Ideal applicants share the company's commitment to its Triple Bottom Line Principle, a strategic initiative focused on financial, social, and environmental responsibility and sustainability.

As an employer, Novo Nordisk offers an opportunity for its team to positively impact the well-being of the greater global community by improving treatments and results for people with diabetes and chronic diseases. It has also been recognized as one of "Canada's Top 100 Employers," one of Forbes magazine's "Most Sustainable Companies," and among "America's 100 Best Adoption-Friendly Workplaces."

Since 1923, Novo Nordisk, an international healthcare company, has been a world leader in diabetes care. With a people-centered approach, the company aims to be an impetus for comprehensive change in diabetes care, education, and public policy. Novo Nordisk also plays a leading role in growth hormone therapy, hormone replacement therapy, and hemophilia care, providing high-quality products to hundreds of countries around the world.